NCCN Practice Guidelines for Prostate Cancer.
Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities, such as cryoablation, are also likely, and will bring even more options for local control. It is certain these guidelines will continue to evolve.
Bahnson
R R
RR
James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, USA.
Hanks
G E
GE
Huben
R P
RP
Kantoff
P
P
Kozlowski
J M
JM
Kuettel
M
M
Lange
P H
PH
Logothetis
C
C
Pow-Sang
J M
JM
Roach
M
M
Sandler
H
H
Scardino
P T
PT
Taylor
R J
RJ
Urban
D A
DA
Walsh
P C
PC
Wilson
T G
TG
D019317:Evidence-Based Medicine; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D010166:Palliative Care; D011159:Population Surveillance; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000628:therapy*; D012307:Risk Factors; D016879:Salvage Therapy; D014481:United States